Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Foster

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
European Urology|June 5, 2007
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate GroupJames A Eastham, Michael W Kattan, Paul Fearn, et al.
Urologia Internationalis|August 3, 2017
Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal BiopsiesGiancarlo Marra, David Eldred-Evans, Ben Challacombe, et al.
Histopathology|December 17, 2009
Overexpression of RAD51 occurs in aggressive prostatic cancerAnita Mitra, Charles Jameson, Yolanda Barbachano, et al.
BJU International|November 6, 2007
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and gradingDaniel M Berney, Gabrielle Fisher, Michael W Kattan, et al.
Oncogene|June 9, 2004
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcomeChristopher S Foster, Alison Falconer, Andrew R Dodson, et al.
International Journal of Oncology|November 5, 2015
Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implicationsShiva Seyed Forootan, Joe M Butler, Derek Gardener, et al.
Pathology|September 22, 2010
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancerSakunthala C Kudahetti, Gabrielle Fisher, Laurence Ambroisine, et al.
Plos One|July 30, 2011
siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancerAlix Bee, Daniel Brewer, Carol Beesley, et al.
Breast Cancer Research and Treatment|September 13, 2005
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissuePauline J Carder, Claire E Murphy, Peter Dervan, et al.
EMBO Reports|May 8, 2010
Molecular origin of plasma membrane citrate transporter in human prostate epithelial cellsMaciej P Mazurek, Puttur D Prasad, Elangovan Gopal, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
European Urology|June 5, 2007
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate GroupJames A Eastham, Michael W Kattan, Paul Fearn, et al.
Urologia Internationalis|August 3, 2017
Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal BiopsiesGiancarlo Marra, David Eldred-Evans, Ben Challacombe, et al.
Histopathology|December 17, 2009
Overexpression of RAD51 occurs in aggressive prostatic cancerAnita Mitra, Charles Jameson, Yolanda Barbachano, et al.
BJU International|November 6, 2007
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and gradingDaniel M Berney, Gabrielle Fisher, Michael W Kattan, et al.
Oncogene|June 9, 2004
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcomeChristopher S Foster, Alison Falconer, Andrew R Dodson, et al.
International Journal of Oncology|November 5, 2015
Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implicationsShiva Seyed Forootan, Joe M Butler, Derek Gardener, et al.
Pathology|September 22, 2010
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancerSakunthala C Kudahetti, Gabrielle Fisher, Laurence Ambroisine, et al.
Plos One|July 30, 2011
siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancerAlix Bee, Daniel Brewer, Carol Beesley, et al.
Breast Cancer Research and Treatment|September 13, 2005
A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissuePauline J Carder, Claire E Murphy, Peter Dervan, et al.
EMBO Reports|May 8, 2010
Molecular origin of plasma membrane citrate transporter in human prostate epithelial cellsMaciej P Mazurek, Puttur D Prasad, Elangovan Gopal, et al.
Pageof 8